A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients

RecruitingOBSERVATIONAL
Enrollment

1,070

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Atypical Hemolytic Uremic Syndrome(aHUS)
Trial Locations (37)

Unknown

RECRUITING

Research Site, Beijing

RECRUITING

Research Site, Luzhou

RECRUITING

Research Site, Baoding

RECRUITING

Research Site, Beijing

RECRUITING

Research Site, Changsha

RECRUITING

Research Site, Chengdu

RECRUITING

Research Site, Chongqing

RECRUITING

Research Site, Foshan

RECRUITING

Research Site, Fuzhou

RECRUITING

Research Site, Guangzhou

RECRUITING

Research Site, Guizhou

RECRUITING

Research Site, Haikou

RECRUITING

Research Site, Hangzhou

RECRUITING

Research Site, Hefei

RECRUITING

Research Site, Huai'an

RECRUITING

Research Site, Jinan

RECRUITING

Research Site, Luoyang

RECRUITING

Research Site, Nanchang

RECRUITING

Research Site, Nanchong

RECRUITING

Research Site, Nanjing

RECRUITING

Research Site, Nanning

RECRUITING

Research Site, Ningbo

RECRUITING

Research Site, Qingdao

RECRUITING

Research Site, Shanghai

RECRUITING

Research Site, Shenyang

RECRUITING

Research Site, Shenzhen

NOT_YET_RECRUITING

Research Site, Shijiazhuang

RECRUITING

Research Site, Shijiazhuang

RECRUITING

Research Site, Suzhou

RECRUITING

Research Site, Taiyuan

RECRUITING

Research Site, Tianjin

RECRUITING

Research Site, Ürümqi

RECRUITING

Research Site, Wuhan

RECRUITING

Research Site, Xi'an

RECRUITING

Research Site, Xiamen

RECRUITING

Research Site, Xuzhou

RECRUITING

Research Site, Zhengzhou

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY